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Abstract. Standardising care can improve patient safety and outcomes, and re-
duce the cost of providing healthcare services. Caremaps were developed to 
standardise care, but contemporary caremaps are not standardised. Confusion 
persists in terms of terminology, structure, content and development process..  
Unlike existing methods in the literature, the approach, model and notation pre-
sented in this chapter pays special attention to incorporation of clinical decision 
points as first-class citizens within the modelling process.  The resulting caremap 
with decision points is evaluated through creation of a caremap for women with 
gestational diabetes mellitus. The proposed method was found to be an effective 
way for comprehensively specifying all features of caremaps in a standardised 
way that can be easily understood by clinicians. This chapter contributes a new 
standardised method, model and notation for caremap content, structure and de-
velopment. 
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1 Introduction 
Florence Nightingale introduced formal and descriptive documentation that would 
transform healthcare and become a vital component of effective care delivery [1]. Clin-
ical care process specification (CCPS), or care modelling, which allows clinicians to 
create, amongst other things, caremaps that specify the workflow to be followed in car-
ing for a patient suffering from a specific health condition [2] were developed from 
Nightingale’s notation and reporting methods. While some CCPS present as templates 
to guide evidence-based care, others provide templates for charting individual patient 
needs, metrics or treatments. CCPS ensure continuity and quality of care for the patient 
[3, 1]. Most contemporary clinical documents were developed and refined during the 
1980’s and 1990’s in response to a number of key needs, including: (i) the need to 
control costs; and, (ii) to improve the quality of patient care [4, 5]. Drawing on project 
management (PM) and total quality management (TQM) tools that were more common 
to industry, hospital managers attempted to reengineer hospital care processes with the 
aim of reducing clinical resource use and error rates, and improving patient outcomes 
[6, 7]. In spite of the potential for those reductions, clinical costs have continued to 
increase, and error rates continue to occur with distressing frequency [8]. 
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Although the British Medical Association and Royal College of Nursing developed 
a joint guidance stating that use of standardised forms are beneficial in reducing varia-
tion in healthcare practice [9], a wide range of terms exist for CCPS, including:  
 
• Clinical practice guidelines (CPG) [10] which are sometimes also known 
as: 
o Consensus-based guidelines (CBG) [11]; and,  
o Local operating procedures (LOP) [12, 13];  
• Clinical decision rules (CDR) [14];  
• Clinical pathways [15];  
• Care plans [16];  
• Treatment protocols [17]; and  
• Caremaps [2, 18]. 
 
The key issue limiting the effectiveness of these terms is that authors do not agree 
on whether some of them represent distinct clinical documents [19-21], or are synony-
mous [22-24]. There is a clear lack of standardisation of definitions, presentations and 
development processes for most types of clinical documentation. While, for some of 
these terms, standardisation has been attempted, these attempts have either been incom-
plete or only further added to the confusion [25, 18, 26]. The use of different terms and 
versions of the same clinical care specification in different units within the same care 
facility, and between different care facilities, is becoming a serious problem. In the 
modern, increasingly digital, healthcare environment greater amounts of data are gen-
erated and captured daily, including from diagnostic devices used, or sensors worn by 
the patient while in the community. Any differences in the documentation approach or 
data recording method results in fragmented data, complicates the integration of data 
about the same patient from different sources, and inhibits health information exchange 
(HIE) [27, 28]. 
Researchers have proposed different approaches to develop CCPS and different 
ways of specifying them [25, 18]. These approaches vary greatly in their complexity 
level, design approach, content and representational structures [25, 18]. These variances 
lead to substantial and ubiquitous differences in communication and information trans-
fer between clinicians providing care for the same patient. This affects the quality of 
care and introduces additional risk of harm for as many as 25% of all patients [29, 28]. 
Error reporting documentation is another area that also suffers from lack of standardi-
sation. While clinicians and clinical researchers are professionally obliged and assumed 
to be honest and transparent in reporting identified errors, it is unlikely that current error 
statistics are representative of the entire scope of the problem [30-32]. 
Standardised CCPS ensures sufficiently high-quality information is recorded, ena-
bling documents to be read quicker and content within to be better retained, all with the 
effect of improving overall patient safety and outcomes [29, 33, 34, 18, 35]. Standard-
ised approaches to CCPS, ensure that each time a healthcare provider approaches each 
type of CCPS, the format and content are consistent with expectations [18]. 
Standardisation of CCPS brings many other benefits than purely operational or clin-
ical. For example, a common problem with most clinical data is that they lack one or 
more of the elements of integrity, integration and interoperability (III). This has been 
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described as the data triple-I issue [36] and is presently seen as one of the biggest single 
barriers to Learning Health Systems (LHS) [36, 37]. Standardisation of CCPS make 
possible the support to mitigate the data triple-I issue, particularly computer interpret-
ability, which in turn supports data standardisation and increases the chances for suc-
cessful EHR and LHS implementation [37]. 
Unfortunately, there has been little research into the standardisation of caremaps and 
other results of clinical care process modelling [38, 39]. [25]. The objective of this chap-
ter is to address this challenge by exploring a model and graphical notation that makes 
it easy for clinicians to understand and allow clinicians to comprehensively specify 
caremaps. 
Supporters perceive care processes standardisation as an effective approach for drop-
ping healthcare service variations and delivery cost, while at the same time maintaining 
or even increasing efficacy, quality and safety, improving patient experience and qual-
ity of life [40, 41]. However, healthcare is still one of the slowest sectors to accept and 
implement process standardisation, and to prove the positive impact on patient out-
comes [42, 41]. This is due to clinician resistance as care standardisation is considered 
by many as ‘cookbook’ or ‘cookie cutter medicine’ that can only be effective after they 
have ruled out the unique needs of each individual [43-45, 41]. Given the overconsump-
tion and financial crisis common to healthcare service delivery globally, standardisation 
of care processes can help clinicians provide managed care that is thought to decrease 
resource consumption and overall healthcare cost, and the incidence of inappropriate 
or ineffective care [46, 47]. 
Standardisation vs Innovation 
Standardisation is ubiquitous in our daily lives [48]. Examples might include the USA’s 
CAFÉ and similar international fuel economy standards used to govern efficiency and 
emissions of new motor vehicles offered for sale [49]; standards instituted for termi-
nology and language, especially for mission-critical applications like satellite and aer-
onautical navigation systems [50] and air traffic control [51]; and standards used to 
ensure safe development, testing, production, prescription and administration of medi-
cines [52, 53]. Standardisation has been described as the activity of establishing and 
recording a limited set of solutions to actual or potential matching problems directed at 
benefits for the party or parties involved in balancing their needs and intending and 
expecting that these solutions will be repeatedly or continuously used during a certain 
period by a substantial number of the parties for whom they are meant [54]. Standards 
generally consist of rules, guidelines, templates or characteristics for activities, or their 
results, that are provided for common and repeated use [55].  
Innovation involves the development and implementation of a new or significantly 
improved product, service or process, and includes all scientific, technological, organ-
isational, financial and commercial steps which are, or are intended to lead to the im-
plementation of the innovation [56, 57]. Innovation in technology and strategy is both 
a catalyst for modern economic growth [58, 56], and standardisation [59, 60].  Yet 
standardisation, especially that which is unofficial or voluntary, is believed to be some-
thing that innately inhibits innovation [56, 61]. Growing insight into the role standard-
isation plays in enabling innovation is forcing reconsideration of this belief [56, 48, 62]. 
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Several approaches have demonstrated the beneficial role standards can have in sup-
porting innovation. Interoperability standards describe how different components in an 
ecosystem work together, for example, the hardware and software in ICT systems [63]. 
Anticipatory standards describe the operation and interoperation of components of fu-
ture systems not yet in operation [64]. Formal standards are high-quality but have a 
considerable development lead time as they are carefully deliberated by standards-writ-
ing organisations, such as the International Standards Organisation (ISO) and Interna-
tional Engineering Task Force (IETF) [65]. De facto standards autonomously stem from 
processes and interactions within the ecosystem, such as the dominance of Microsoft’s 
operating system in personal computing or resilience of the QWERTY keyboard layout 
which while being originally designed to mitigate adjacent keys jamming on early me-
chanical typewriters, is still seen on devices like touch screens which have no moving 
parts [65, 63]. Standards can also be described in terms of their particularisation or 
extent to which they are standardised: whether the organisation, service or approach is, 
for example, wholly, or largely, standardised [66]. 
Motor vehicle production and use is restrained by a great many standards: directing 
safety, materials application, pollution, operation and maintenance. The same standards 
governing fuel efficiency and emissions discussed earlier, and which have removed 
many vehicles with inefficient large-bore engines from sale, actually stimulated inno-
vation. This innovation includes the recently released homogenous charge gasoline 
compression engines using a system described as Spark Controlled Compression Igni-
tion (SCCI). SCCI is claimed to reduce fuel consumption by as much as 20% [67, 68]. 
The standards also produced competition in innovation with another major vehicle 
manufacturer also releasing new technology this year, the Variable Compression Tur-
bocharged (VC-T) engine [69]. There were also innovations that delivered the fully 
electric vehicle (fEV) by Tesla: a product that sits in a market space that can only con-
tinue to innovate in order to meet anticipated standards requiring all passenger/com-
muter vehicles to become electric [70, 71]. While the standards discussed operate to 
ensure that motor vehicles marketed today cause less pollution, they do not, for exam-
ple, act inhibit a manufacturers choice of colour, luxury options or the model name that 
might adorn your next vehicle. And as we have seen, far from inhibiting innovation, 
standards can beneficially support novel innovations.  
When it comes to the practice of medicine, a large array of standards applies to al-
most every action a clinician may seek to undertake. Built on a base of clinical practice 
guidelines, evidence-based medicine is perhaps the most broadly applied and well-
known standardisation in medicine [26, 72]. This work investigates standardisation in 
the context of health informatics, finding current efforts often focus on some element 
of how the clinician interacts with the system, data entry, composition or presentation. 
In this review, no example was located that was investigating the potential for funda-
mental underlying issues to have arisen when non-standardised clinical documentation 
was digitised by a variety of hospitals and health sectors in the creation of EHR plat-
forms. The clinical documentation that HIS and the now ubiquitous EHR were engaged 
to replace should be investigated as one potential source giving rise to the barriers that 
inhibited HIS and EHR adoption, and which currently restrain integration of LHS in 
clinical practice. 
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2 Literature Review and Related Works 
Caremaps Background 
The term caremap refers to a graphical representation of the sequence of patient care 
activities to be performed for a specific medical condition suffered by either a patient 
or a cohort [73-75]. Caremaps have been in use, in one form or another, for around forty 
years [6, 76, 7].  Caremaps aim to standardise health care practice by organising and 
sequencing care workflow, ensuring standard of care, timely interventions and uniform 
outcomes using an appropriate level of resources [77, 25, 76, 73]. Caremaps also help 
track variance in clinical practice, as they provide a simple and effective visual method 
for identifying when care practice has deviated from the routine evidence-based path-
way [78, 73]. 
The literature presents three different descriptions for the origin of caremaps, with 
distinct points of intersection between each that make it difficult to assess which may 
be the true history: 
  
1. Caremaps were an output of the Centre for Case Management (CCM) 
in 1991 [79]. CCM’s CareMaps were similar in form and function to 
existing clinical pathways and were applied to specific patient popu-
lations that were commonly treated in many hospitals [79].  CCM went 
on to trademark the double-capitalised version CareMap but had not 
within the first decade undertaken any research to demonstrate the ef-
fectiveness of the concept whose invention they claimed [80]. 
2. Caremaps naturally evolved as an expansion of earlier case manage-
ment and care plans [7]. 
3. Caremaps were developed during the 1980’s at the New England Med-
ical Centre (NEMC) [81, 75]. 
Caremaps arose in nursing where they incorporate and extend the critical pathways and 
bring established project management methodologies into healthcare delivery [62, 57, 
24]. Indeed, from the early 1980’s nurses were the primary users of caremaps [68, 44].  
Caremap Terminology 
Definitions from literature of the early- to mid 1990’s in principle agreed that the 
caremap presents as a graph or schedule of care activities described on a timeline and 
performed as part of the patient’s treatment by a multidisciplinary team to produce 
identified health outcomes [77, 2, 76, 73-75, 7]. Even though the structure and content 
of caremaps has changed markedly during the last three decades, this general definition 
still applies. 
Caremaps can be observed under three similar but different titles: (i) caremaps; (ii) 
CareMaps; and (iii) care maps. The first, caremaps, appears to have been the original 
title prior to the CCM trademarking the second, CareMaps, in the early 1990’s [77, 79]. 
In literature published after 1994 that uses the first, caremaps, it is not uncommon to 
also see some mention of CCM or their trademark [82] although this is not always the 
case [83, 84]. The use of care maps has also been seen, possibly as a defence to potential 
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issues that might arise from confusion with the CCM trademark, as no author used this 
third type in context or with reference to the CCM [73, 85]. 
 There is disagreement on whether caremaps are a separate format of clinical tool 
[19-21], or simply another term for care pathways, clinical pathways, critical pathways 
and care plans [22-24]. This disagreement is exemplified by flow diagrams that are 
internally describe as a “care map”, yet are captioned ‘clinical pathway’ by the author 
(e.g. in Figure 1 of Thompson et al [86] and Figure 5 on page 45 of Yazbeck [87]). 
Yazbeck (ibid) further presents a number of similar flow diagrams for care manage-
ment, describing them using a range of terms including ‘care map’, ‘care pathway’, and 
‘algorithm’. 
Caremap Evolution and Current Context 
Starting in the early 1990’s, Nursing caremaps were more textual than their contempo-
rary counterparts, and had a structure made up of two components: (1) Problem and 
Outcomes Specification: identifying patient problems and necessary outcomes within a 
time-frame; and (2) Task and Activity Specification: a breakdown and description of 
day-by-day tasks and activities on a critical path [73, 74]. Later approaches specified 
the care map in three components: (1) the flow chart diagram; (2) the transitional text-
based care map of activities broken down day-to-day, and; (3) the evidence base relied 
upon in their construction [78]. These methods of specifying and presenting the 
caremap may have resulted in the terminology confusion that still persists today. More 
recent caremaps are specified as a flow diagram made up of clinical options for a par-
ticular condition. Thus, modern caremaps contain multiple possible paths based on: (i) 
symptomatology; (ii) diagnostic results, and; (iii) how the patient responds to treatment 
[88, 89].  
Traditional caremaps considered elements such as anxiety, rehabilitation, education, 
prevention and coping strategies and were intended to restore the patient as close to a 
normal quality of life as was possible given their diagnosis [73-75]. Starting from 1999 
there began to be examples of transitional caremaps: while still being text-based, these 
were limited to interventions necessary to treat the primary diagnosis [25, 82]. As 
caremaps evolved into graphical representations we observe contemporary caremaps 
presented as separate but complementary components to the clinical pathway or CPG 
[79, 84]. A summary of the relevant elements of each caremap type is presented in 
Table 1. 
Table 1. Summary and comparison of caremap evolution stages (from [18]) 
 Traditional 
(1980’s to mid-1990’s) * 
Transitional 
(Mid-1990’s to mid 2000’s) * 
Contemporary 
(2004 onwards) * 
Primary 
Author 
Nurses Nurses and Doctors Doctors 
Context Holistic Primary condition Single diagnostic, screening 
and/or intervention event. 
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Foci Restoring the patient to 
normal life 
Outcomes, cost and resource 
consumption 
Efficiency of care delivery 
and outcomes, reduction of 
practice variation, bridge the 




Text-based Text-based with some early 
flow examples 
Flow diagram or graph 
Status Independent document Independent or sometimes in-
corporated with CP document 
Self-contained but often 
found appended to/con-
tained in CPG 
 
Caremaps are found in many healthcare domains, including: paediatric surgery [88], 
nursing [89], oncology [90], diagnostic imaging [91], obstetrics [4] and cardiology 
[76]. Even within these examples, there exists significant variance in complexity level, 
design approach, content and the representational structures used. 
Related Works: Efforts to Standardise Caremaps 
Numerous contemporary caremap examples were found annexed to hospital-based clin-
ical CPGs. Contemporary caremap literature tended to focus on establishing the clinical 
condition justifying creation of the caremap, such as: determination of incidence, risk 
factors and patient outcomes [88]; diagnosis and stabilisation of patients with an acute 
presentation [89]; and, protocolising of ongoing treatment [85]. Presentation or discus-
sion of a development process or the elements used in construction were rare, and more 
often had to be inferred from a thorough reading of each paper. 
We found a single article written by a veterinarian and a lawyer which attempted a 
systematic description of the process for contemporary caremap development [92]. This 
article primarily focused on standardisation for the purpose of cost containment, and 
provides an example of mapping for a surgical procedure [92].  Given their focus and 
particular caremap construction model which, through their own exemplar application, 
only includes a temporally-ordered single-path representation of the gross steps of pa-
tient care, their paper was at best, merely formative. By their own admission, they de-
liberately limited relevant data analysed during the input design phase to what they felt 
was truly critical for identifying and understanding outliers. This results in a model 
lacking clinical applicability and a distinct lack of detail surrounding each care process. 
Their method requires significant work to adequately support true standardised clinical 
caremap development. 
Hospital management and clinical literature opinions changed during the early 
2000’s, with a distinct focus shift towards the theme of standardisation [93, 6, 94, 7]. 
Researchers, politicians, those engaged in hospital governance, and some clinicians 
recognised standardisation should be considered of paramount importance to the future 
of healthcare delivery [94]. Standardisation of such things as clinical decisions, diag-
nostic and therapeutic methods, evidence-based guidelines, care approaches, practice 
standards and clinical information was sought [95, 8, 94, 5]. Standardisation in the 
name of quality care and outcomes would become the single-minded national focus of 
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healthcare service delivery for entire countries [95, 5]. Promoted with great passion, 
this type of standardisation has seen multiple teams within the same country, or even 
within the same organisation, expending effort on developing standardisation frame-
works with some degree of similarity and overlap [96-98]. However, this drive towards 
standardisation has had little effect on the definition, development and structure of 
much of the current clinical documentation, because as we approached the end of the 
first full decade of standardisation, calls for standardised clinical care documents con-
tinue to increase [95, 99, 38, 18, 39, 100]. An unmet need can also be seen in calls to 
resolve poorly standardised taxonomy and nomenclatures currently used in developing 
and cataloguing clinical documentation [101]. 
3 Research Process and Methodology 
Literature Review: A search was conducted across a range of databases using the terms 
‘caremap’, ‘CareMap’, and ‘care map’. A citation search drawn from all included pa-
pers was also performed. This search identified 1,747 papers. Once duplicates, papers 
not based in the nursing, medical or healthcare domains, and those using the term “care 
map” in other contexts were removed a core pool of 115 papers remained. 
Development of Review Framework Using Thematic Analysis: Initially, each paper 
was reviewed using content and thematic analysis [102] and concept analysis [103] to 
identify and classify terminology, construction and content elements and to infer the 
caremap development processes. 
Methodology for Standardisation of Caremaps: Literature reviews have a ground-
level consensus forming function that allows for identification of implementation tech-
niques and the degree of accord between authors within a domain [104, 105]. The lit-
erature pool was used to identify common definition, structure and content elements for 
caremaps. In addition, process steps that were consistently described led us to a stand-
ardised caremap development process. 
Methodology for Evaluation of Proposed Standard for Caremaps: Case Studies are a 
grounded comparative research methodology with a well-developed history, robust 
qualitative procedures and process validation [106]. The case study approach provides 
a real-life perspective on observed interactions and is regularly used in information sci-
ences [107, 108]. Case studies are considered as developed and validated as any other 
scientific method and are an accepted method where more rigid approaches to experi-
mental research cannot or do not apply [109, 110]. The standardised development pro-
cess and resulting caremap are both evaluated using case studies of examples from the 
authors’ other works. 
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4 Standardisation of Caremaps: Exemplar for Standardising 
CCPS 
Clinical Decisions in Caremaps 
Graphically modelling patient care for a given medical condition is not new. Several 
approaches and presentation styles have been proposed, including: UML process mod-
elling to represent the ongoing clinical management of a chronic condition [111]; busi-
ness process modelling notation (BPMN) to visually map the treatment flow captured 
in clinical pathways [112]; and, influence diagrams to model the structure of complex 
clinical problems, identifying decisions to be made, the sequence in which those deci-
sions may arise, the information available to make the decision and the probability of 
uncertain events [113]. Caremaps presentation style and content has changed signifi-
cantly since their conception in the 1980’s. Currently, contemporary caremaps used in 
clinical medicine present as an immature information visualisation approach [18]. 
Apart from lacking standardisation, existing caremaps lack also a comprehensive rep-
resentation of clinical decision points (DP). 
Until recently, caremaps lacked standardisation in structure, content and develop-
ment [18]. The authors proposed and presented what is stated here as TaSC (Towards 
a Standard for Caremaps): a model for standardising the development and presentation 
of clinical caremaps [18]. Based on TaSC, each node within the caremap represents 
activities related to patient care. In addition, nodes are often seen to represent one or 
more latent clinical decisions, such as selecting the appropriate treatment path for each 
patient. Our prior work has pointed out the presence of these latent DPs within caremaps 
as well as the absence of a way to identify and represent them [18]. This chapter ex-
plores these issues and proposes an extension to TaSC for identifying and representing 
DPs with decision criterion.  
 There are several clinical decisions that might be embedded within a caremap 
node. For instance, a treatment activity may require the clinician to consider whether 
aseptic technique is required, which dressing to use or which clinical resource to assist 
during treatment. The majority of these decisions have no direct impact on the flow of 
care or the pathway of the patient within the caremap. Thus, only decisions that have 
an impact on the path to be taken by the patient should be considered as separate DPs 
within the caremap.  
Clinical decisions that may lead to DPs in a caremap result from six aspects of clin-
ical activities identified by Richardson et al [114] as follows: 
 
Clinical Evidence: The identification and selection of clinical evidence 
from clinical trials and clinical practice guidelines for use in creating 
tools like caremaps necessitates decisions regarding how to gather the 
right clinical findings properly and interpret them soundly.  
Diagnosis: During diagnosis decisions are made regarding the selection 
and interpretation of diagnostic tests.  
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Prognosis: Prognosis requires decisions of how to anticipate a given 
patient’s likely course.  
Therapy: Therapy decisions consider how to select treatments that do 
more good than harm.  
Prevention: Screening and reducing a patient’s risk for disease preven-
tion decisions.  
Education: Consideration of how to teach the clinician, patient or pa-
tient’s family what is needed fall within the remit of education deci-
sions. 
5 Approach and Method for Standardising the Model and 
Notation for Caremap Specifications 
This section describes the current state, and potential starting point for any standard 
for caremaps, as resolved from the review of the literature.  
Caremap Development Process with Consensus Formation 
The literature was used initially to establish consensus on common structure, content 
and development processes that had previously been used in the creation of caremaps, 
and which may be relevant in defining standard caremap and development processes. 
The case studies were used to evaluate and refine the elements of each.  
 
To address the stated aim of this research, we focused our research on tertiary care 
(hospital-borne) caremaps and specifically the following three components whose char-
acteristics came out of the thematic analysis, and make up the review framework. 
 
Structure What is the representational structure and notation for expressing contempo-
rary caremaps? 
Content What content types are consistently seen in contemporary caremaps? 
Development What are the process steps followed for developing contemporary caremaps? 
Standardising the Caremap Structure 
Each caremap flow diagram identified from the literature had its own visual element 
and notation style. The most common observed was a rectangle for representing the 
process step, which are usually called an activity. Contemporary caremaps contain a set 
of nodes that represent patient care activities. However, the literature shows there is no 
consistency in the way an activity may be represented. Different shapes including rec-
tangular boxes with rounded [86] or squared corners [93, 115, 85], plain text [79], or 
even arrows [116] have been used. In some cases, activities that diverge to different 
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and mutually exclusive pathways may be represented by a diamond [23, 115]. The flow 
from one activity to another has been illustrated with arrows [88, 78, 115], or simple 
lines [79, 23]. The literature also lacks clarity as to whether a caremap should have 
entry and exit points. In some cases, neither is present [78, 86], while in others these 
points are an implicit [23] or explicit part of the diagram [115]. Finally, most caremaps 
contained multiple pathways and were sometimes presented as multi-level flow charts 
[93, 115]. 
Standardising the Caremap Content 
An activity in the caremap represents a specific medical process. Three broad medical 
activities that are regularly observed are; diagnosis, treatment and ongoing monitoring/ 
management [117, 86].  A set of desired outcomes is a common caremap component 
[88, 93, 115, 85]. Time, presented either as a duration or a dynamic care process, is 
often included in the caremap [84]. Finally, an explanation related to the activities and/ 
or the arrows might also be part of the caremap [88, 78, 84, 86]. The former helps to 
better describe an activity, while the latter to justify the flow transition from one activity 
to another and/or the path to be taken based on the clinical decision being made. 
Standardising the Caremap Development Process 
The process of developing a contemporary caremap is a research topic that has been 
frequently neglected. Only one in every six papers gives any information concerning 
the development process. Unfortunately, very few papers provide any clear description 
of the development process [44, 117, 86]. For the remaining, the caremap development 
process can only be inferred [79, 115, 85]. 
6 TaSC: Proposed Standard for Caremaps 
This section presents a solution for standardising caremap structure and content, and an 
approach for caremap development distilled directly from analysis of the CCPS litera-
ture. During the course of refining and evaluating TaSC the presence of previously un-
described DPs that would be assistive in identifying the appropriate treatment path for 
patients was realised. As a result, TaSC also incorporates a standard approach to de-
scribing DPs relevant to path selection, and based around the six aspects of clinical 
work from which clinical decisions arise listed earlier. 
Standardising Caremap Structure 
The TaSC entity relationship model shown in Figure 2 describes the relationships 
among the caremap’s structural elements. All elements and their notation are presented 
in Table 2. The standardised structural model for the caremap is then demonstrated in 
the content model shown in Figure 3. 
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Figure 2: An Entity Relationship model for the caremap 
 
Figure 2 presents the model for the caremap specification that we believe has the key 
features necessary to comprehensively specify a clinical caremap by using a minimal 
set of representational constructs or elements. The representational elements of the 
caremap in this model lead to a representation notation that is simple and easy for cli-
nicians to understand and use in authoring caremaps. In the caremap model, which is 
presented by using the UML class diagram, the caremap can either nest or link to an-
other caremap. A caremap contains Pathways such that each present as a sequence of 
Elements. These include the Activity nodes within which clinical efforts occur, as well 
as the functional EntryPoint, ExitPoint, ExclusionPoint and DecisionPoint (DP) ele-
ments. Each DP represents some clinical decision to be made based on one or more 
Criterion, which can include such things as the patient’s risk factors, symptomatology 
and response to treatment, and often as identified from the results of clinical tests. The 
Pathway describes both: (i) the timing of necessary activities, that is, when activities 
should occur and how long to wait before performing the next activity; and, (ii) the 
route or selected order of events identified as a result of the impact of DP Criterion. 
Corresponding to each representational construct presented in the caremap model in 
Figure 2, a set of notational elements have been designed to allow caremaps to be spec-
ified according to the model. Table 2 presents the notation to represent each caremap 
element in the model. The notation is inspired by the standardised pictorial approach of 




Table 2: The TaSC Content type, activities and decisions (adapted from [18]) 
 Element Description Notation 
1 Entry point Beginning of the caremap  
2 Exit point End of the caremap 
 
3 Exclusion point Exclusion from the caremap, as the patient does not belong 
to the targeted population  
4 Activity A care or medical intervention that is associated with a med-
ical content type (see Table X in next section)  
5 Nested Activity An activity that has an underlying caremap 
 
6 Decision A cognitive process of selecting a course of action that is as-
sociated with a medical content type (see Table X in next sec-
tion) 
 
7 Nested Decision A decision that has an underlying caremap 
 
8 Flow Transition from one activity to another along the pathway  
9 Multiple pathways Flow from an antecedent activity to a number of successors 
from which a decision point arises 
 
10 Decision Criterion Conditional values used to identify the path to be taken based 
on the clinical decision being made  
11 Nested caremap 
connection 
Connection between an activity and its nested caremap  
12 Multi-level caremap 
connection 






Figure 3: The TaSC content model for the caremap (adapted from [18])  
Standardising Caremap Content 
Diagnosis, treatment and ongoing management/ monitoring are the three main con-
tent types captured in TaSC. As shown in Table 3, these three broad content types are 
related to a set of specific medical activities, the information captured, and relevant 
DPs. Finally, referring back to the content model presented previously in Figure 3 we 
see that each content type represents a different caremap level, and that the activities 
and decisions are components of the caremap 
Table 3: Caremap content type, activities, data and decisions (adapted from [18]) 
Content 
Type 











Review patient records Demographics 
Medical history 
    
 
 
Is there a suspicion of 
the targeted disease? 





Ask personal, lifestyle ques-
tions 
Habits (risk factors) 
Clinical examination Signs/ Symptoms 
Targeted examination Diagnostic test results  
Has the initial suspi-






Set goals Expected outcomes  
 
 
Is the considered treat-







Variances from expected out-
comes 











Have the goals been 
achieved? 
 
Is there a need to 
change the current 
treatment? 
Clinical examination Signs/ Symptoms 
Targeted examination Diagnostic test results 
Evaluate goals Progression 
Standardising the Caremap Development Process 
TaSC development process is divided into 6 phases, as shown in Figure 4. The de-
velopment steps have been clustered into three primary groups: (a) those undertaken 
before caremap development commenced; (b) those undertaken during development 
and refinement of the caremap, and; (c) those that come after the caremap has been 
refined and approved for implementation. At first, the conceptual framework should be 
decided and a multidisciplinary team should be assembled. In the next phase it is im-
portant to clarify and challenge current practice. The knowledge and current data should 
be studied and potential variations from the current practice should be anticipated. Re-
viewing and evaluating the available evidence is the last phase before caremap devel-
opment. Figure 4 illustrates that as new knowledge becomes available and more lessons 




Figure 4: Caremap development lifecycle [18] 
7 Evaluation: A Study Using TaSC to Develop and Specify 
Caremaps in a Standardised Way 
As part of a project to design and build LHS intended to reducing clinical overuse 
while empowering patients to actively participate in their own healthcare, the EPSRC-
funded PAMBAYESIAN project (www.pambayesian.org) is creating Bayesian Net-
work (BN) models to predict treatment needs for individual mothers with gestational 
diabetes mellitus (GDM). The process initially required us to create three caremaps for: 
(1) diagnosis; (2) management, and; (3) postnatal follow up. 
Inputs: Inputs were: (a) clinical practice guidelines for the care of women with diabetes 
in pregnancy; and, (b) review and consensus from midwives and diabetologists. 
Development: An iterative development process was used wherein the decision scien-
tist and midwifery fellow worked together to deliver an initial version of the caremap 
based on the CPG and clinical experience. This initial caremap was revised and refined 
during a number of sessions with clinicians. Figure 5a presents the resulting clinical 
management caremap for GDM. 
Extending the Caremaps: While using the caremaps to develop BNs for supporting 
diagnostic and treatment decisions for GDM we found the process was significantly 
simpler and more efficient when latent decisions relevant to selecting the appropriate 
treatment path for patients, and embedded in each caremap, were identified and in-
cluded in the caremap. The GDM caremaps were redeveloped as caremaps with DPs. 
Figure 5b shows the same clinical management caremap, however the DP have now 
been expounded in place of the previous activity node. 
Validation: Validation was performed through consultation seeking consensus from 
three diabetologists with tertiary care experience of obstetric patients managed using 
the CPGs used in the caremaps’ creation. 
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Figure 5: (a) GDM Management without DP [18]                  (b) GDM Management with DP 
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8 Summary and Conclusions 
Standardisation of care through the means of guidelines and caremaps is sometimes 
seen as limiting clinicians' ability to make decisions based on the patient presenting 
before them, seemingly giving rise to cookie-cutter medicine. A range of clinical care 
process specification (CCPS) documents exist. The disagreement that persists within 
the domain regarding their name, form and function shows that they are not standard-
ised. This lack of standardisation can put patients at risk, and has in some cases, caused 
harm. One type of CCPS, caremaps, are a form of standardised clinical documentation 
that can improve patient safety and outcomes while prompting clinicians with infor-
mation and visual cues necessary to clinical decisions regarding the appropriate treat-
ment path for their patients. Caremaps have evolved during the last three decades from 
primarily text-based presentations developed by nurses, to flow-based visual aids pre-
pared by doctors to be representative of diagnostic and treatment processes. These con-
temporary caremaps have been presented in a variety of ways and with vastly different 
levels of content. Contemporary caremaps lacked standardisation. 
This chapter presented one solution for standardising caremap structure, content and 
clinical decisions, and an approach for caremap development distilled directly from 
analysis of the collected pool of academic literature. The development process was 
evaluated and refined during the development of caremaps for management of patients 
with GDM. The resulting caremaps were validated by expert consensus. 
If used consistently, the methods presented in this chapter could bring standardisa-
tion to caremaps and ensure that as clinical staff move between busy units in a tertiary 
care setting, they are not distracted from the patient in an effort to understand the care 
flow model. Every caremap would be familiar and time can be given over to treating 
their patient, not trying to understand the document. 
Future work should address a standard approach for digital development and impu-
tation of the caremap by clinicians, and representation of caremap logic in other com-
puter-aware and algorithmic forms including BNs and Influence Diagrams (Fenton and 
Neil 2018). These can form part of an LHS and aid in the making of population-to-
patient level predictions about treatment and health outcomes. 
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